Heparin-induced thrombocytopenia and thrombosis
Article Abstract:
Research has shed light on the paradoxical association between heparin-induced thrombocytopenia and the development of blood clots in surgical patients who receive heparin. Heparin-induced thrombocytopenia is a drop in the number of blood cells called platelets that can occur when the body forms antibodies against heparin. However, several 1994 studies revealed that the antibodies are not against heparin, but against heparin bound to platelet factor 4, a chemical found in platelets. These antibodies could bind to chemicals similar to heparin on the inside of blood vessels and damage them. This could lead to the formation of blood clots. A 1995 study found that none of the 330 surgical patients who received low-molecular-weight heparin developed thrombocytopenia. They were also less likely to develop antibodies against heparin than patients who received standard heparin.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1995
User Contributions:
Comment about this article or add new information about this topic:
Drug-induced immune thrombocytopenia
Article Abstract:
The conditions in which the exposure to a drug has led to the destruction of circulating platelets, often accompanied by bleeding symptoms, are examined. Patients with drug-induced thrombocytopenia should avoid permanently the medication that might cause this condition.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Bleeding during thrombolytic therapy for acute myocardial infarction: mechanisms and management. Adjuncts to thrombolysis for myocardial reperfusion
- Abstracts: Hypothalamic amenorrhea: clinical perspectives, pathophysiology, and management. Cerebrospinal fluid levels of corticotropin-releasing hormone in women with functional hypothalamic amenorrhea
- Abstracts: Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura